Allergan, Inc. News Headlines

AGN 
$211.95
*  
1.83
0.87%
Get AGN Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Novartis' Alcon's Travatan Obtains Label Expansion in the EU - Analyst Blog
12/26/2014 3:05:00 PM - Zacks.com


Roche' (RHHBY) Blood Cancer Drug Gazyva's Label Updated - Analyst Blog
12/26/2014 2:50:00 PM - Investopedia


Roche' (RHHBY) Blood Cancer Drug Gazyva's Label Updated - Analyst Blog
12/26/2014 2:50:00 PM - Zacks.com


Novartis' Alcon's Travatan Obtains Label Expansion in the EU - Analyst Blog
12/26/2014 3:05:00 AM - Investopedia


Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
12/23/2014 6:05:00 PM - Zacks.com


Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog
12/23/2014 5:45:00 PM - Zacks.com


Keryx (KERX) Launches Renal Drug Auryxia in the U.S. - Analyst Blog
12/23/2014 4:35:00 PM - Zacks.com


Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical
12/23/2014 12:45:00 PM - Seeking Alpha


Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
12/23/2014 6:05:00 AM - Investopedia


Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog
12/23/2014 5:45:00 AM - Investopedia


Keryx (KERX) Launches Renal Drug Auryxia in the U.S. - Analyst Blog
12/23/2014 4:35:00 AM - Investopedia


Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog
12/22/2014 5:51:00 PM - Zacks.com


AstraZeneca's Lynparza Cleared in U.S. for Ovarian Cancer - Analyst Blog
12/22/2014 5:45:00 PM - Zacks.com


Roche to Acquire Austrian Biotechnology Company Dutalys - Analyst Blog
12/22/2014 4:55:00 PM - Zacks.com


Farallon Capital sells stake in Oracle Corp.
12/22/2014 3:39:00 PM - Market Realist


Novo Nordisk's Tresiba Favored by CHMP for Expanded Use - Analyst Blog
12/22/2014 3:10:00 PM - Zacks.com


XLV, BIIB, ACT, AGN: Large Inflows Detected at ETF
12/22/2014 12:11:24 PM - BNK Invest


Farallon Capital increases stake in Shire
12/22/2014 11:39:00 AM - Market Realist


Farallon Capital raises stake in Allergan
12/22/2014 9:39:00 AM - Market Realist


Energy Sector Seen as Biggest Risk to Deal Flow in 2015
12/22/2014 9:00:00 AM - Fox Business


Allergan, Inc. (AGN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
12/22/2014 7:00:00 AM - Investopedia


Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog
12/22/2014 5:51:00 AM - Investopedia


AstraZeneca's Lynparza Cleared in U.S. for Ovarian Cancer - Analyst Blog
12/22/2014 5:45:00 AM - Investopedia


Roche to Acquire Austrian Biotechnology Company Dutalys - Analyst Blog
12/22/2014 4:55:00 AM - Investopedia


Novo Nordisk's Tresiba Favored by CHMP for Expanded Use - Analyst Blog
12/22/2014 3:10:00 AM - Investopedia